학술논문 – 부산대학교 도서관

학술논문

replay검색결과 돌아가기

search검색화면

KEYNOTE-052: Phase 2 study of pembrolizumab (MK-3475) as first-line therapy for patients (pts) with unresectable or metastatic urothelial cancer ineligible for cisplatin-based therapy.

Document Type

Journal

Author

Bajorin, Dean F.; Plimack, Elizabeth R.; Siefker-Radtke, Arlene O.; Choueiri, Toni K.; De Wit, Ronald; Sonpavde, Guru; Gipson, Adrianna; Brown, Holly; Mai, Yabing; Pang, Lei; Perini, Rodolfo F.; Bellmunt, Joaquim

Source

JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2015, 33 15, 1p. Supplement: S

Subject

Language

English

ISSN

15277755

Online Access

Web of Science JCR 저널정보 Find it@PNU

이메일